Are HFOT and NIV Complementary for Acute Respiratory Failure?



F. Javier Belda, MD, PhD

Professor of Anesthesiology and Critical Care.

Department of Surgery. Faculty of Medicine and Odontology.

University of Valencia. Spain



With the widespread utilization of noninvasive ventilation (NIV) for the treatment of respiratory failure, as well as the increasing utilization of humidified high flow oxygen therapy (HFOT) for the treatment of various forms of respiratory compromise, clinicians now have a broader range of noninvasive tools aimed at managing acute respiratory failure. However, the precise indication of each one of these therapies is still a question of debate. This webinar is intended to provide a more detailed comparative understanding of the clinical application of NIV, HFOT and Conventional Oxygen Therapy (COT), to show differences and similarities in modes of action, and to analyze the scientific evidence on the clinical benefits when these technologies are compared.


Learning Objectives:

After the completion of this activity, the learner will be able to:

  1. Discuss the physiological  effects of HFOT for its clinical application in ARF

  2. Discuss the evidence for the use of HFOT in ARF

  3. Describe the comparative effects and outcomes of HFOT, NIV and COT in ARF.


Faculty Bio:

F Javier Belda, MD, PhD, is Professor of Anesthesiology at the Department of Surgery,University of Valencia, Spain and  is affiliated with the  Department of Anesthesia and Critical Care in the Hospital Clinico Universitario (Valencia, Spain). He is member of the Education and Training Committee and the EDAIC-2 Subcommittee (ESA, EU), and past member of the Respiratory Subcommittee (ESA) and Critical Care Program of the ATS (USA). He has participated in more than 40 national and international projects focused in ventilatory strategies for prevention and treatment of lung injury. He is editor of 15 books, and author of more than 220 research papers and. He is reviewer for JAMA, Lancet, Anesthesiology, EJA, Critical Care Medicine and other high impact journals. Prof. Belda has been an invited speaker in more than 500 international conferences and other teaching events.   

Supported by an educational grant 

Philips Healthcare

Philips logo copy.png